Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Oda B Wijers"'
Autor:
Artuur M. Leeuwenberg, Johannes B. Reitsma, Lisa G.L.J. Van den Bosch, Jeroen Hoogland, Arjen van der Schaaf, Frank J.P. Hoebers, Oda B. Wijers, Johannes A. Langendijk, Karel G.M. Moons, Ewoud Schuit
Publikováno v:
Leeuwenberg, A M, Reitsma, J B, Van den Bosch, L G L J, Hoogland, J, van der Schaaf, A, Hoebers, F J P, Wijers, O B, Langendijk, J A, Moons, K G M & Schuit, E 2023, ' The relation between prediction model performance measures and patient selection outcomes for proton therapy in head and neck cancer ', Radiotherapy and Oncology, vol. 179, 109449 . https://doi.org/10.1016/j.radonc.2022.109449
Radiotherapy and Oncology, 179:109449. Elsevier Ireland Ltd
Radiotherapy and Oncology, 179:109449. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 179:109449. Elsevier Ireland Ltd
Radiotherapy and Oncology, 179:109449. ELSEVIER IRELAND LTD
BACKGROUND: Normal-tissue complication probability (NTCP) models predict complication risk in patients receiving radiotherapy, considering radiation dose to healthy tissues, and are used to select patients for proton therapy, based on their expected
Autor:
Karel G.M. Moons, Johanna G M van den Hoek, Lisa Van den Bosch, Oda B. Wijers, Johannes A. Langendijk, Johannes B. Reitsma, Roel J H M Steenbakkers, Hans Paul van der Laan, Ewoud Schuit, Arjen van der Schaaf, Frank J. P. Hoebers
Publikováno v:
Radiotherapy and Oncology, 157, 147-154. Elsevier Ireland Ltd
Radiotherapy and oncology, 157, 147-154. Elsevier Ireland Ltd
Radiotherapy and Oncology, 157, 147-154. ELSEVIER IRELAND LTD
Radiotherapy and oncology, 157, 147-154. Elsevier Ireland Ltd
Radiotherapy and Oncology, 157, 147-154. ELSEVIER IRELAND LTD
Background and purpose: A comprehensive individual toxicity risk profile is needed to improve radiation treatment optimisation, minimising toxicity burden, in head and neck cancer (HNC) patients. We aimed to develop and externally validate NTCP model
Autor:
Klaas T van der Laan, Jan L. N. Roodenburg, Johanna G M van den Hoek, Jan G. A. M. de Visscher, Oda B Wijers, Kees Ahaus, Lidia S van Huizen, Pieter U. Dijkstra, Gyorgy B. Halmos
Publikováno v:
BMJ Open
BMJ Open, 9(11):028609. BMJ PUBLISHING GROUP
BMJ Open, 9(11):028609. BMJ PUBLISHING GROUP
ObjectivesGiven the difficulties in diagnosing and treating head-and-neck cancer, care is centralised in the Netherlands in eight head-and-neck cancer centres and six satellite regional hospitals as preferred partners. A requirement is that all patie
Autor:
Oda B. Wijers, Stefan Both, H. P. van der Laan, A. Van der Schaaf, Johannes A. Langendijk, E. Shuit, Frank J. P. Hoebers, L. Van den Bosch, Roel J H M Steenbakkers
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 105(1), E384-E385. ELSEVIER SCIENCE INC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73ab88b3a4f7936c04e1b3259b4288d3
https://research.rug.nl/en/publications/3170af7b-8c3a-48c4-b6a4-a48bc83b79b6
https://research.rug.nl/en/publications/3170af7b-8c3a-48c4-b6a4-a48bc83b79b6
Autor:
Johannes A. Langendijk, A. Van der Schaaf, L. Van den Bosch, Ewoud Schuit, Roel J H M Steenbakkers, Oda B. Wijers, H. P. van der Laan, E. Bakker, A. M. Van der Wel, F. J. P. Hoebers
Publikováno v:
Radiotherapy and Oncology. 133:S104-S105
Autor:
Ruud Wiggenraad, J. Heukelom, Theo Gregor, Jan-Jakob Sonke, Jan de Boer, Alfons J. M. Balm, I. Bing Tan, Oda B. Wijers, Coen R.N. Rasch, Marcel Verheij, Jan Buter, Marta Lopez-Yurda
Publikováno v:
Head & Neck. 38:E488-E493
Background The radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) phase III trial compared intra-arterial (IA) to intravenous (IV) cisplatin-based chemoradiation for head and neck cancer. Long-term efficacy and toxi
Autor:
Jolien, Heukelom, Marta, Lopez-Yurda, Alfons J M, Balm, Oda B, Wijers, Jan, Buter, Theo, Gregor, Ruud, Wiggenraad, Jan Paul, de Boer, I Bing, Tan, Marcel, Verheij, Jan-Jakob, Sonke, Coen R, Rasch
Publikováno v:
Headneck. 38
The radiation and concomitant high-dose intra-arterial or intravenous cisplatin (RADPLAT) phase III trial compared intra-arterial (IA) to intravenous (IV) cisplatin-based chemoradiation for head and neck cancer. Long-term efficacy and toxicity are re
Autor:
Henrie van der Est, M. Braaksma, Peter C. Levendag, Oda B. Wijers, Peter J.C.M. Nowak, Paul I.M. Schmitz, John R. van Sörnsen de Koste
Publikováno v:
Radiotherapy and Oncology. 66:291-302
Purpose : Prevention of damage to critical normal tissues is of paramount importance for the quality of life of patients irradiated for cancers in the head and neck. The purpose of this paper was to evaluate the parotid gland sparing 3D conformal rad
Autor:
Frank J. Lagerwaard, Inge Noever, Connie de Pan, Arent van Nimwegen, Peter C. Levendag, Peter J.C.M. Nowak, Oda B. Wijers
Publikováno v:
Radiotherapy and Oncology. 63:67-74
Purpose : The aim of the study is to define the role and type of high-dose, high-precision radiation therapy for boosting early staged T1,2a, but in particular locally advanced, T2b-4, nasopharyngeal cancer (NPC). Materials and methods : Ninety-one p
Autor:
Meindert Boonzaaijer, Peter C. Levendag, Paul I.M. Schmitz, Leo L. Visch, Oda B. Wijers, M. Braaksma
Publikováno v:
Head & Neck-Journal for the Sciences and Specialties of the Head and Neck, 24, 737-747. John Wiley & Sons Inc.
Background. Xerostomia can have a significant impact on the quality of life of patients treated by radiation therapy (RT) for cancer in the head and neck. The first aim of the study was to evaluate the degree of xerostomia in 39 long-term survivors t